FABP5:fatty acid binding protein 5
Both ileus and bowel obstruction are medical emergencies
This, along with more strict requirements for indication of need for PPIs, as suggested by the AGA, and periodic reevaluations of efficacy could possibly aid in prevention of PPI associated side effects
excluded participants demonstrates that the excluded group is generally comparable to the included group in terms of sociodemographic and health-related factors (Table S1)
By promoting GH release, Tesamorelin may possibly enhance lipolysis, reduce visceral adipose tissue, and also potentially improve glucose metabolism
For comparison, semaglutide alone achieved approximately 14.9% in the STEP 1 trial, and tirzepatide achieved approximately 20.9% in SURMOUNT-1 at 72 weeks